US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, including advancing the company’s bird flu vaccine, as fears of a new ...

US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, including advancing the company's bird flu vaccine, as fears of a new ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

The H5N1 virus is common in wild birds and other animals. While it has not conclusively been found to spread from person to ...

The version of the virus spreading in North America right now has led to only a few serious cases, but concerns have been ...

Outgoing agency Chair Lina Khan has filed a raft of measures during her last week in office. The current public-health risk is low, but the CDC is watching the situation carefully and working with ...

Moderna secured a $590 million package from the U.S. Health and Human Services Department to accelerate the development of its bird influenza vaccine. The financial package will fund the expansion of ...

Moderna secured a $590 million package from the U.S. Health and Human Services Department to accelerate the development of its bird influenza vaccine as concerns about a bird flu pandemic in humans ...

The current public-health risk is low, but the CDC is working with states to monitor people with animal exposure.

As fears grow of a possible bird flu pandemic in humans, the federal government is pouring more money into the development of new vaccines, including an mRNA shot.

HHS is investing more than $800 million in vaccine development and manufacturing capacity to strengthen the nation's response capabilities to emerging infectious disease threats, including bird flu.